Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
- PMID: 35956081
- PMCID: PMC9369763
- DOI: 10.3390/jcm11154464
Factors Modulating COVID-19: A Mechanistic Understanding Based on the Adverse Outcome Pathway Framework
Abstract
Addressing factors modulating COVID-19 is crucial since abundant clinical evidence shows that outcomes are markedly heterogeneous between patients. This requires identifying the factors and understanding how they mechanistically influence COVID-19. Here, we describe how eleven selected factors (age, sex, genetic factors, lipid disorders, heart failure, gut dysbiosis, diet, vitamin D deficiency, air pollution and exposure to chemicals) influence COVID-19 by applying the Adverse Outcome Pathway (AOP), which is well-established in regulatory toxicology. This framework aims to model the sequence of events leading to an adverse health outcome. Several linear AOPs depicting pathways from the binding of the virus to ACE2 up to clinical outcomes observed in COVID-19 have been developed and integrated into a network offering a unique overview of the mechanisms underlying the disease. As SARS-CoV-2 infectibility and ACE2 activity are the major starting points and inflammatory response is central in the development of COVID-19, we evaluated how those eleven intrinsic and extrinsic factors modulate those processes impacting clinical outcomes. Applying this AOP-aligned approach enables the identification of current knowledge gaps orientating for further research and allows to propose biomarkers to identify of high-risk patients. This approach also facilitates expertise synergy from different disciplines to address public health issues.
Keywords: COVID-19; SARS-CoV-2 infection; adverse outcome pathway; age; co-morbidities; environment; lifestyle; modulating factors; pre-existing conditions; sex.
Conflict of interest statement
The authors declare no conflict of interest. This study is solely associated with individual scientist participation and their expressions of interest and opinions; it does not represent the official position of any institution.
Figures
References
-
- Nymark P., Sachana M., Leite S.B., Sund J., Krebs C.E., Sullivan K., Edwards S., Viviani L., Willett C., Landesmann B., et al. Systematic Organization of COVID-19 Data Supported by the Adverse Outcome Pathway Framework. Front. Public Health. 2021;9:638605. doi: 10.3389/fpubh.2021.638605. - DOI - PMC - PubMed
-
- Ankley G.T., Bennett R.S., Erickson R.J., Hoff D.J., Hornung M.W., Johnson R.D., Mount D.R., Nichols J.W., Russom C.L., Schmieder P.K., et al. Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment. Environ. Toxicol. Chem. 2010;29:730–741. doi: 10.1002/etc.34. - DOI - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous
